Peripheral administration of IL-6 in mice induces insulin resistance [8,9], and peripheral IL-6 antibody neutralisation of IL-6 in a transgenic diabetes mouse model improves hepatic insulin sensitivity [10]. The gene discussed is INS; the disease is Insulin resistance.